Business Wire

Work Connected with the Olympus Scientific Cloud

Jaa

The new Olympus Scientific Cloud expands the capabilities of the EPOCH® 6LT flaw detector and Vanta handheld XRF analyzer at no extra cost, with more features planned in the coming months. A suite of new capabilities, including wireless software updates, easy data backups, and real-time screen sharing for Vanta analyzers help make your work faster and more efficient.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005101/en/

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Olympus is constantly improving the software of our instruments. The Olympus Scientific Cloud (OSC) enables users to wirelessly download the latest software updates directly to their instrument without having to use a PC interface program. When an update for the Vanta analyzer is available, a notification will appear in the device’s user interface, prompting the user to download. EPOCH 6LT users can check the Cloud web application for updates. For fleet managers, this functionality helps ensure that all of the EPOCH 6LT flaw detectors and Vanta analyzers in their fleet are operating on the same software version for reliable, reproducible results.

Once data has been acquired, the Olympus Scientific Cloud makes it easy to back it up and share it with others. Operators can wirelessly upload their data to the Cloud, even while they are still in the field. Users no longer have to worry about maintaining a large backlog of files on their instrument or running out of space. Once the data is in the Cloud, colleagues back in the office or on the other side of the world can see the data for fast, efficient collaboration. The data files can also be transferred in open formats, like CSV, so users can easily access their data using their preferred software.

The OSC has powerful new management functionality. Fleet managers can monitor health parameters of their devices, such as active time, error logs, and temperature.* Managers can also use the OSC to keep track of how much each device is used to help ensure that the work is distributed evenly across the fleet. If an instrument needs to be serviced, the Cloud helps the Olympus service center know what components and software need updating or servicing to minimize downtime.

For Vanta analyzers, the OSC offers additional benefits, including:

  • Screen sharing: users in the field can share their analyzer’s screen with decision-makers back in the office.
  • Advanced fleet management: managers can track the last reported physical location of all of their analyzers.
  • Automatic data uploads: data automatically uploads (or is sent) to the Cloud as soon as you complete a test.

The benefits and functionality of the Olympus Scientific Cloud are paired with leading-edge security features. With a network of data centers located all over the world, users can be assured that their data is stored securely and locally. All data uploaded to the Olympus Scientific Cloud remains the property of the customer; Olympus does not share or use customer data that is stored in the Cloud.

*Health data varies per instrument.

About Olympus

Olympus Corporation operates in industrial, medical, and consumer markets, specializing in optics, electronics, and precision engineering. Olympus is a world-leading manufacturer of innovative test and measurement solutions that are used in industrial and research applications ranging from aerospace, power generation, petrochemical, civil infrastructure, and automotive to consumer products.

For more information about the Olympus Scientific Cloud and Olympus’ full line of nondestructive testing products, contact a sales representative or visit http://www.olympus-ims.com/.

Olympus and EPOCH are registered trademarks, and Vanta is a trademark of Olympus Corporation.

Contact information

Olympus Corporation
Calvin Jory, 781-419-3549
Calvin.Jory@olympus-ossa.com
or
Michelle Wright, 781-419-3664
Michelle.Wright@olympus-ossa.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Ipsen and Exelixis announce phase 3 trial results of cabozantinib demonstrating significant overall survival benefit in patients with previously treated advanced hepatocellular carcinoma17.1.2018 01:05Tiedote

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) and Exelixis, Inc. (NASDAQ:EXEL) today announced detailed results of the pivotal phase 3 CELESTIAL trial in patients with previously treated advanced hepatocellular carcinoma (HCC), which will be presented in a late-breaking oral session at the 2018 ASCO-GI Symposium being held in San Francisco, January 18-20, 2018. In CELESTIAL, cabozantinib provided a statistically significant and clinically meaningful improvement versus placebo in overall survival (OS), the trial’s primary endpoint, at the planned second interim analysis (prespecified critical p value ≤ 0.021) for the population of second- and third-line patients enrolled in this study. Median OS was 10.2 months with cabozantinib versus 8.0 months with placebo (HR 0.76, 95 percent CI 0.63-0.92; p=0.0049). Median progression-free survival (PFS) was more than doubled, at 5.2 months with cabozantinib and 1.9 months with placebo (HR 0.44, 95 percent CI 0.36-0.52; p<0.0001). Objective resp

IFF to Release Fourth Quarter & Full Year 2017 Results February 1417.1.2018 00:15Tiedote

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, announced that it will release its fourth quarter and full year 2017 earnings results following the market close on Wednesday, February 14, 2018. The management team will host a live webcast on Thursday, February 15, 2018 at 10:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumer

President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit16.1.2018 22:17Tiedote

For the 6th year in a row, President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, will deliver keynote remarks at the 6th Annual World Patient Safety, Science and Technology Summit held in London, England, February 23-25, 2018. President Clinton, who serves as Honorary Chair of the Patient Safety Movement Foundation’s Regional Network Chairs, joins an acclaimed group of global leaders, government representatives, healthcare and hospital CEOs, medical experts and patient advocates who will gather for the first time in London to confront preventable hospital deaths around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180116006614/en/ President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, to speak at the 6th Annual World Patient Safety, Science & Technology Summit in London, England (Photo: Business Wire) “We are thrilled

Disaronno: The Mixing Star Makes a Step Change and Looks to Innovation16.1.2018 19:06Tiedote

After 10 years of competitions involving bartenders from different countries who were challenged to showcase the mixability of Disaronno, Disaronno’s contest The Mixing Star has changed direction. Convinced that trends today move on channels other than a performance in front of a jury, Disaronno, the most consumed Italian liqueur in the world and the brand embodying the coolest soul of Made in Italy, has transformed The Mixing Star to Innovation Hunter, a social media based "exploration" with a mission: identifying innovative trends in mixology and movers and shakers in the field, in the UK and around the world, filming and sharing them with the community of bartending experts. In London, Milan and Amsterdam Disaronno has selected a few bartenders who are revolutionizing the field. The ways in which they express innovation have been collected in a set of stylish short movies specially made by Disaronno. The protagonists are available on The Mixing Star Facebook page and YouTube channel

Christie’s Announces Public Preview Tour Dates for The Collection of Peggy and David Rockefeller16.1.2018 18:54Tiedote

Christie’s is pleased to confirm additional dates and locations for public preview exhibitions of the Collection of Peggy and David Rockefeller. Following the unveiling of early highlights in Hong Kong last November, Christie’s will now tour property to its flagship galleries in London (February 21 – March 8), Beijing (April 6 - 7), Los Angeles (April 6 – 12), and Shanghai (April 10 - 11), leading up to the auctions at Christie’s Rockefeller Center in New York in late spring. With each stop on the pre-sale tour, additional works of art and objects will be unveiled, revealing new facets of this storied, multi-category collection. The exhibitions, which are open to the public, are sponsored in partnership with private aviation company VistaJet. As a guide for collectors, Christie’s has launched a special issue of Christie’s Magazine dedicated to the Collection of Peggy and David Rockefeller. The issue re-acquaints readers with the Rockefeller family’s unique place in American history, an

Continuum Accelerates Global Expansion with Portland Europe16.1.2018 18:00Tiedote

Continuum ®, the exclusive provider of the only vertically integrated IT service delivery platform that enables MSPs to scale rapidly and profitably, today announced that it has signed a distribution agreement with Portland Europe, a leading distributor of scalable software solutions for the reseller channel throughout the Benelux region. The partnership will provide Portland Europe’s wide network of managed solution providers (MSPs) in the Benelux region with access to Continuum’s fully-managed remote monitoring and management (RMM) platform, powered by the company’s network operations center (NOC). Continuum’s platform has been proven to enable MSPs to efficiently manage thousands of customer endpoints, giving them back the resources to focus on higher-end, more profitable tasks at a time when skilled IT workers are highly sought-after. As opposed to having to correspond with multiple vendors, Portland Europe customers will benefit from having Continuum serve as a single point of con

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme